Source: San Diego Union-Tribune
Date: December 20, 2007
Summary:
The San Diego Union-Tribune reports International Stem Cell Corporation has created embryonic stem cell lines that are a genetic match to patients, potentially eliminating risks of immune system rejection:
"In a step toward one-size-fits-all stem cell therapies, an Oceanside biotechnology company said yesterday that it has developed cell lines that could potentially be used by many different people and races without fear of transplant rejection. Scientists at International Stem Cell Corp. said the four embryonic stem cell lines have a simple genetic profile in critical areas of DNA that code for immune system rejection, making them easy to “immune match” with large numbers of patients."
